Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02010632Phase 1Completed
Phase 1 trial of clopidogrel in myocardial infarction (MI), ischemic stroke and Peripheral Arterial Disease (PAD), sponsored by Khon Kaen University. Primary endpoint: Platelet Inhibition Effect of Clopidogrel at 24 hours. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02010632.